ViVitro Labs at EuroPCR 2024

May 1st, 2024

ViVitro Labs at EuroPCR

Connect with Jérémie Decressac, ViVitro Labs Business Development Manager, Europe, Africa, Israel, at EuroPCR in Paris, France at the Palais des congrès from 14-17 May 2024.

Building on the success of EuroPCR 2023’s record-breaking 11,500+ onsite and online participants, registrations are now open for this 2024 edition. Taking place on 14-17 May, this event promises to bring together renowned cardiovascular professionals, introduce cutting-edge innovations, and facilitate meaningful discussions..

Jérémie Decressac

 

Meet with Jérémie Decressac, ViVitro Labs Business Development Manager, Europe, Middle East, Africa & Asia, at EuroPCR in Paris, France to discuss your cardiovascular device testing and engineering challenges.

 

 

ViVitro Heart Valve Prosthesis AWT System

ViVitro Labs Heart Valve Durability Tester with ADC™ technology

With Dual Control Technology (DCT)™ for constant leaflet closing velocities during the entire AWT cycling period

ViVitro’s AWT System with DCT™ uses two separate position feedback sensors and algorithms to maintain constant leaflet closing velocities across the entire AWT cycling period. Piston displacement and bypass valve are controlled independently to meet differential pressure requirements while preserving initial leaflet closing velocities.

  • Patent pending Dual Control Technology to maintain constant leaflet closing velocities during Accelerated Wear Testing (AWT) and Dynamic Failure Mode (DFM)
  • Maximum versatility with pre-wired controller unit and data acquisition system for easy PnP upgrade of up to 6 test modules
  • True standalone architecture with independent test modules to avoid disruptions to adjacent on-going test
  • Transparent test chambers with inflow, outflow, and lateral visibility for optimum test samples visualization during testing
  • Patent pending flow loop system to operate system under low hydrostatic pressure conditions and avoid the need for an external pressure source

Learn more about the ViVitro Heart Valve Prosthesis AWT System and ViVitro Labs at Innovation Summit Dublin 2024! Book time with Jérémie Decressac, ViVitro Labs Business Development Manager, Europe, Middle East, Africa & Asia


ViVitro Pulse Duplicator system

 

The ViVitro Pulse Duplicator system is the world’s most widely cited and most used in-vitro cardiovascular hydrodynamic testing system.

The ViVitro Pulse Duplicator simulates the function of the heart (left or right) by generating pulsatile flow through prosthetic heart valves placed in the Model Heart (Left or Right). Powered by the ViVitro SuperPump pulsatile pump, it is composed of the ViVitro Model Heart (Left or Right), SuperPump pulsatile pump, Flow Measuring System and ViViTest data acquisition system. The components work together to assess the performance of prosthetic heart valves under simulated cardiac conditions. The ViVitro Pulse Duplicator System is used by the US Food and Drug Administration and is recognised and used by regulatory bodies worldwide including TÜV, BSI and Chinese CFDA.

The Pulse Duplicator System assesses the performance of cardiovascular devices and prosthetic heart valves under simulated cardiac conditions. It simulates physiological or other complex flow variations while allowing the user to vary the peripheral resistance and compliance of the system. Pressure ports and flow measuring locations allow for data to be collected from aortic or mitral sites. Transparent viewpoints allow multiple viewing angles of the valve including inflow and outflow.

Combined with the ViVitest software control system, it quickly, easily and reliably collects and analyzes physiological flow and pressure data. The ViVitest software also allows the user to easily modify and customize waveforms.

View ViVitro Pulse Duplicator web page.

The ViVitro Pulse Duplicator System is cited in numerous research studies throughout the world. Visit our Citation Database for the current list of applications and articles.

Learn more about the ViVitro Pulse Duplicator and ViVitro Labs at EuroPCR in Paris, France! Book time with Jérémie Decressac, ViVitro Labs Business Development Manager, Europe, Middle East, Africa & Asia, to discuss your cardiovascular device testing and engineering challenges.


Cardiovascular Device Testing Services

ViVitro Labs offers cardiovascular device testing services as either ISO 17025:2017 accredited or non accredited to help device manufacturers meet the highest standards in the industry in support of regulatory submissions.

Meet with Jérémie Decressac, ViVitro Labs Business Development Manager, Europe, Middle East, Africa & Asia at EuroPCR in Paris, France to discuss your cardiovascular device testing and engineering challenges.

    Join over 5000 cardiovascular device professionals who receive our testing and engineering insights and tips every month.